France
# |
Name |
Shareholders' Equity |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 81.72 B
|
Dec. 31, 2023 | USD 107.78 | 1.15% |
|
France |
|
2 |
USD 4.22 B
|
Dec. 31, 2023 | USD 125.57 | 1.43% |
|
France |
|
3 |
USD 4.14 B
|
Dec. 31, 2023 | USD 121.52 | 0.77% |
|
France |
|
4 |
USD 2.91 B
|
Dec. 31, 2023 | USD 223.78 | 0.44% |
|
France |
|
5 |
USD 1.02 B
|
Dec. 31, 2023 | USD 3.27 | -1.63% |
|
France |
|
6 |
USD 993.71 M
|
Dec. 31, 2023 | USD 329.80 | 0.09% |
|
France |
|
7 |
USD 581.69 M
|
Dec. 31, 2023 | USD 75.53 | 2.94% |
|
France |
|
8 |
USD 434.50 M
|
Dec. 31, 2023 | USD 26.48 | -1.30% |
|
France |
|
9 |
USD 417.58 M
|
Dec. 31, 2023 | USD 28.61 | 0.98% |
|
France |
|
10 |
USD 242.03 M
|
Dec. 31, 2023 | USD 37.82 | -0.43% |
|
France |
|
11 |
USD 216.35 M
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
12 |
USD 193.35 M
|
Dec. 31, 2023 | USD 26.53 | -0.92% |
|
France |
|
13 |
USD 140.19 M
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
14 |
USD 137.39 M
|
Dec. 31, 2023 | USD 1.18 | 2.98% |
|
France |
|
15 |
USD 111.00 M
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
16 |
USD 84.69 M
|
Dec. 31, 2023 | USD 1.61 | 2.90% |
|
France |
|
17 |
USD 75.00 M
|
Dec. 31, 2023 | USD 3.91 | 3.55% |
|
France |
|
18 |
USD 71.32 M
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
|
19 |
USD 57.29 M
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
20 |
USD 28.27 M
|
Dec. 31, 2023 | USD 1.89 | 0.25% |
|
France |
|
21 |
USD 25.19 M
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
22 |
USD 24.94 M
|
Dec. 31, 2023 | USD 4.49 | 2.38% |
|
France |
|
23 |
USD 21.63 M
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
24 |
USD 19.19 M
|
Dec. 31, 2023 | USD 3.53 | -0.92% |
|
France |
|
25 |
USD 14.57 M
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
26 |
USD 8.74 M
|
Dec. 31, 2023 | USD 1.27 | 1.92% |
|
France |
|
27 |
USD 566.80 K
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
|
28 |
USD 386.25 K
|
Dec. 31, 2023 | USD 1.97 | -1.32% |
|
France |
|
29 |
USD -2.03 M
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
30 |
USD -5.82 M
|
Dec. 31, 2023 | USD 2.03 | 3.98% |
|
France |
|
31 |
USD -7.63 M
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
32 |
USD -13.21 M
|
Dec. 31, 2023 | USD 2.06 | -0.75% |
|
France |
|
33 |
USD -23.19 M
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
34 |
USD -35.36 M
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
35 |
USD -44.05 M
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
The Pharmaceuticals company in France with the highest Shareholders' Equity is Sanofi (Paris Stock Exchange: SAN.PA) at USD 81.72 B.
The Pharmaceuticals company in France with the lowest Shareholders' Equity is MedinCell S.A. (Paris Stock Exchange: MEDCL.PA) at USD -44.05 M.
The top 10 Pharmaceuticals companies in France by Shareholders' Equity are Sanofi, Ipsen S.A., bioMérieux S.A., Sartorius Stedim Biotech S.A., Euroapi S.A., Virbac SA, Vetoquinol SA, Boiron SA, Guerbet SA and Equasens SA.
The bottom 10 Pharmaceuticals companies in France by Shareholders' Equity are MedinCell S.A., Inventiva S.A., AB Science S.A., Advicenne S.A., Adocia SA, Crossject SA, Nanobiotix S.A., NFL Biosciences SA, Predilife S.A. and ABIONYX Pharma SA.